ARCHIVES

DCT board Okays Recompetition of Clinical Trials Contracts

This article is from The Cancer Letter archive.

Vol. 19 No. 42 | October 29, 1993

Download PDF Visit The Full Archive

Related Articles

Arimidex Continues To Show Improvement Over Tamoxifen

December 27, 2002

Gonzalez-Angulo Found Guilty in MD Anderson Poisoning Case

September 26, 2014

NCI Issues Statement On Endostatin Research

October 1, 1999

SBRT Delivers Higher Overall Survival Rates Compared to Conventional Radiation Therapy

November 30, 2012

Other DCT Concepts Approved By BSC

June 6, 1986

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

July 28, 2000